World's Best Scientists 2026 revealed!
Jean Michon

Jean Michon

D-Index & Metrics

Medicine

D-Index
76
Citations
20219
World Ranking
18816
National Ranking
628

Overview

Jean Michon is affiliated with the Institute Curie in France and has contributed to the field of medicine with a focus on oncology and related subfields. Their research covers surgery, neurology, epidemiology, general health professions, and health. The scientist's work encompasses various topics including vaccine coverage and hesitancy, neuroblastoma research and treatments, hepatitis B virus studies, hepatitis viruses studies and epidemiology, lung cancer research, cancer therapeutics and mechanisms, and lymphoma diagnosis and treatment.

Their frequent publication venues include:

  • Médecine et Maladies Infectieuses Formation
  • Médecine et Maladies Infectieuses
  • Pediatric Blood & Cancer
  • Cancers
  • Journal of Clinical Oncology

Co-authorship is notable with several researchers, including Aurélie Baldolli, Renaud Verdon, Ruth Ladenstein, Ulrike Pötschger, and Dominique Valteau-Couanet, reflecting collaboration across closely related studies and clinical investigations.

Recent papers by Jean Michon demonstrate involvement in multiple aspects of oncology research:

  • Investigation of the Role of Dinutuximab Beta-Based Immunotherapy in the SIOPEN High-Risk Neuroblastoma 1 Trial (HR-NBL1), 2020, published in Cancers
  • Age Dependency of the Prognostic Impact of Tumor Genomics in Localized Resectable MYCN-Nonamplified Neuroblastomas. Report From the SIOPEN Biology Group on the LNESG Trials and a COG Validation Group, 2020, published in Journal of Clinical Oncology
  • Relationships Between Managerial and Organizational Practices, Psychological Health at Work, and Quality of Care in Pediatric Oncology, 2020, published in JCO Oncology Practice
  • Patient management in pediatric oncology during the COVID-19 pandemic: Report from francophone Africa, 2020, published in Pediatric Blood & Cancer
  • In childhood mature B-NHL with CNS disease, patients with blasts in cerebrospinal fluid are at higher risk of failure, 2020, published in Blood Advances

Jean Michon's research participation indicates a multidisciplinary approach combining clinical trials, patient management strategies, and epidemiological studies. The integration of studies on vaccine hesitancy and infectious diseases alongside cancer therapeutics illustrates a broad scope within medical research.

Best Publications

  • Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma

    Isabelle Janoueix-Lerosey;Delphine Lequin;Delphine Lequin;Laurence Brugières;Agnès Ribeiro

  • The Société Française d'Oncologie Pédiatrique LMB89 protocol: highly effective multiagent chemotherapy tailored to the tumor burden and initial response in 561 unselected children with B-cell lymphomas and L3 leukemia

    Catherine Patte;Anne Auperin;Jean Michon;Henk Behrendt

  • Ewing Sarcoma: Current Management and Future Approaches Through Collaboration

    Nathalie Gaspar;Douglas S. Hawkins;Uta Dirksen;Ian J. Lewis

  • Primary Disseminated Multifocal Ewing Sarcoma: Results of the Euro-EWING 99 Trial

    Ruth Ladenstein;Ulrike Pötschger;Marie Cécile Le Deley;Jeremy Whelan

  • Results of the randomized international FAB/LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents: it is possible to reduce treatment for the early responding patients

    Catherine Patte;Anne Auperin;Mary Gerrard;Jean Michon

  • Relapsed neuroblastomas show frequent RAS-MAPK pathway mutations

    Thomas F Eleveld;Derek A Oldridge;Virginie Bernard;Jan Koster

  • A new member of the ETS family fused to EWS in Ewing tumors

    Martine Peter;Jérome Couturier;Hélène Pacquement;Jean Michon

  • Genomic Landscape of Ewing Sarcoma Defines an Aggressive Subtype with Co-Association of STAG2 and TP53 Mutations

    Franck Tirode;Didier Surdez;Xiaotu Ma;Matthew Parker

  • Results of a randomized international study of high-risk central nervous system B non-Hodgkin lymphoma and B acute lymphoblastic leukemia in children and adolescents

    Mitchell S. Cairo;Mary Gerrard;Richard Sposto;Anne Auperin

  • Overall Genomic Pattern Is a Predictor of Outcome in Neuroblastoma

    Isabelle Janoueix-Lerosey;Gudrun Schleiermacher;Evi Michels;Véronique Mosseri

  • Busulfan and melphalan versus carboplatin, etoposide, and melphalan as high-dose chemotherapy for high-risk neuroblastoma (HR-NBL1/SIOPEN): an international, randomised, multi-arm, open-label, phase 3 trial

    Ruth Ladenstein;Ruth Ladenstein;Ulrike Pötschger;Andrew D J Pearson;Penelope Brock

  • Safety assessment of intensive induction with vincristine, ifosfamide, doxorubicin, and etoposide (VIDE) in the treatment of Ewing tumors in the EURO-E.W.I.N.G. 99 clinical trial

    Christine Juergens;Claire Weston;Ian J. Lewis;Jeremy Whelan

  • Interleukin 2 with anti-GD2 antibody ch14.18/CHO (dinutuximab beta) in patients with high-risk neuroblastoma (HR-NBL1/SIOPEN): a multicentre, randomised, phase 3 trial

    Ruth Ladenstein;Ulrike Pötschger;Dominique Valteau-Couanet;Roberto Luksch

  • Peripheral Blood Stem Cell and Bone Marrow Transplantation for Solid Tumors and Lymphomas: Hematologic Recovery and Costs: A Randomized, Controlled Trial

    Olivier Hartmann;Anne Gaelle Le Corroller;Didier Blaise;Jean Michon

  • N-Myc gene amplification is a major prognostic factor in localized neuroblastoma: results of the French NBL 90 study. Neuroblastoma Study Group of the Société Francaise d'Oncologie Pédiatrique.

    H Rubie;O Hartmann;J Michon;D Frappaz

  • Criteria for evaluation of disease extent by 123 I-metaiodobenzylguanidine scans in neuroblastoma: a report for the International Neuroblastoma Risk Group (INRG) Task Force

    K. K Matthay;B Shulkin;R Ladenstein;J Michon

  • Ovarian function after bone marrow transplantation during childhood.

    E Thibaud;K Rodriguez-Macias;C Trivin;H Espérou

  • Multivariate analysis of risk factors in stage 4 neuroblastoma patients over the age of one year treated with megatherapy and stem-cell transplantation: a report from the European Bone Marrow Transplantation Solid Tumor Registry.

    Ruth Ladenstein;T. Philip;C. Lasset;O. Hartmann

  • Emergence of New ALK Mutations at Relapse of Neuroblastoma

    Gudrun Schleiermacher;Niloufar Javanmardi;Virginie Bernard;Quentin Leroy

  • Surgical risk factors in primary surgery for localized neuroblastoma: the LNESG1 study of the European International Society of Pediatric Oncology Neuroblastoma Group.

    Giovanni Cecchetto;Veronique Mosseri;Bruno De Bernardi;Pierre Helardot

Frequent Co-Authors

Olivier Delattre
Olivier Delattre PSL University
François Doz
François Doz Université Paris Cité
Odile Oberlin
Odile Oberlin Institut Gustave Roussy
Wolf H. Fridman
Wolf H. Fridman Université Paris Cité
Peter F. Ambros
Peter F. Ambros St Anna Children's Hospital
Eric Bouffet
Eric Bouffet University of Toronto
Andrew D.J. Pearson
Andrew D.J. Pearson Royal Marsden NHS Foundation Trust
Laurence Brugières
Laurence Brugières Institut Gustave Roussy
Genevieve Laureys
Genevieve Laureys Ghent University Hospital
André Baruchel
André Baruchel Université Paris Cité

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Beyond studying Medicine in the USA, there are diverse online education and career pathways within healthcare. Those interested in managing patient data and records can consider an online health information management degree, which prepares graduates for vital roles in medical data systems.

For individuals seeking administrative positions, an online medical billing and coding certification is a popular, flexible option. These roles are essential in ensuring accurate billing and financial health for medical practices and hospitals.

Nursing is another dynamic field with a range of advancement opportunities. Aspiring nurse practitioners can explore the most cheapest fnp programs online, often designed for working professionals seeking higher credentials.

Additionally, pursuing the cheapest online msn programs allows registered nurses to earn a Master of Science in Nursing, expanding their scope of practice and leadership potential.

Best Scientists Citing Jean Michon

Trending Scientists